Australia's Opyl jumps on expanded dataset for AI platform

Pathkey.AI

29/04/2024 03:50

** Shares of Opyl  OPL.AX  rise as much as 56.3% to A$0.025,
their biggest intraday gain since Sept. 3, 2020
    ** Artificial intelligence-based medical research co says
its AI-driven clinical trial prediction and design optimisation
platform TrialKey has expanded its dataset
    ** Says platform now provides insights based on over 350,000
trials, up from 65,000 trials previously
    ** Over 3.6 mln shares change hands, compared with the
30-day average volume of about 300,000
    ** Stock down 42.9% YTD based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))